Abstract:Objective To study the clinical effect of the application of the interventional embolization of hepatic artery with gelatin sponge particles in the treatment of giant hepatic carcinoma. Methods 91 cases of patients with giant liver cancer were randomly divided into the study group and the control group. The control group only used the iodine oil emulsion in the treatment of hepatic artery interventional chemotherapy embolization. The study group used gelatin sponge particles and iodine oil emulsion combined with the implementation of hepatic arterial chemoembolization. The tumor necrosis rate,the tumor diameter,the level of the fetal protein,liver function,adverse reaction and survival of the follow-up period were compared. Results The tumor necrosis rate in the study group was significantly higher than that in the control group (P < 0. 05). The tumor diameter between two groups had no significant difference (P >0. 05). After 1 month treatment the tumor diameter were significantly reduced (P <0. 05),and the diameter of the tumor in the study group 3 months after treatment was reduced,but had no significant difference compared with 1 month treatment(P > 0. 05). The tumor diameter in the control group was in-creased 3 months after treatment,but there was no significant difference between before operation and 1 months after operation (P >0. 05). There was no significant difference of AFP between the two groups before and after treatment (P > 0. 05),and the two groups were better than before treatment (P <0. 05). The liver function showed no significant difference between the two groups before treatment. After treatment,CHE,ALB,ALT and AST were significantly decreased,and TBIL was not signifi-cantly changed. After treatment,ALB and CHE were significantly decreased, and the other indicators had no significant change. After treatment,the levels of ALT and AST in the study group were significantly higher than those in the control group after treatment,and there were no significant differences between the two groups. There was no significant difference in the in-cidence of adverse reactions between the two groups (P >0. 05). The survival rate of 3 and 6 months after treatment had no significant difference (P >0. 05). The survival rate of 9 months and 12 months after treatment was significantly higher than that of the control group (P < 0. 05). Conclusion Massive type hepatocellular carcinoma (HCC) implementation of he-patic artery interventional embolization with gelatin sponge particles combined with lipiodol emulsion can significantly improve the curative effect in the near future,prolong the survival time of the patients and no significant increase in adverse reactions compared with the simple application of lipiodol emulsion embolization.

Gelatin sponge microparticle combined with recombinant human adenovirus TACE for the treatment of hepatocellular carcinoma

[The Preliminary Study of Recombinant Adenovirus P53 Combined with Transarterial Embolization with Particles for Advanced Hepatocellular Carcinoma].

Recombinant Human Adenovirus P53 Combined with Transcatheter Arterial Chemoembolization for Liver Cancer: a Meta-Analysis

P53 Gene Therapy‐based Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Cohort Study

The Curative Effects and Side Effects of Recombinant Human Adenovirus P53 on Transplanted Gastric Cancer Cells in Nude Mice

[Therapeutic Effect of Adenovirus-Mediated Apoptin Gene Transfer Combined with ADM and CDDP on Hepatocellular Carcinoma in Mice].

Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer.

Multiple Hepatic Arterial Injections of Recombinant Adenovirus P53 and 5-Fluorouracil after Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: a Pilot Phase II Trial.

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Huaier granules combined with intraarterial chemoembolization for the treatment of hepatocellular carcinoma

In Vitro Effect of Recombinant Human Adenovirus p53 Combined with Epirubicin on Human Gastric Cancer Cells

Treatment of Giant Hepatic Carcinoma by Transcatheter Arterial Embolization with Gelatin Sponge Particles with Iodine Oil Emulsion

Effects of Recombinant Human Adenovirus-P53 on the Regression of Hepatic Fibrosis

EFFECT OF RECOMBINANT ADENOVIRUS-p53 COMBINED WITH DOCETAXEL ON THE GROWTH INHIBITION OF HUMAN LUNG ADENOCARCINOMA CELL LINES

Effects of Recombinant Adenovirus-p53 Combined with Oxaliplatin on Growth Inhibition of Human Gastric Cancer Cell Line SGC-7901

Changes in the Peripheral Treg Cell Proportion and Immune Function in Hepatocellular Carcinoma Patients after Transarterial Chemoembolization with Gelatin Sponge Microparticles

Inhibitory Effects of 5-Aza-2′-deoxycytidine and Trichostatin A in Combination with P53-Expressing Adenovirus on Human Laryngocarcinoma Cells

[Effect of Recombinant Adenovirus-P53 on Growth and Chemosensitivity of Human Lung Adenocarcinoma Cell Lines].

Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer

Safety and Primary Efficacy of Recombinant Human Adenovirus-P53 Injection on Advanced Solid Tumor

Recombinant human endostatin combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma